Texas Native Sees Remarkable Improvement in Battle With Multiple Sclerosis After Stem Cell Therapy

March is the official month of National MS Awareness. More than 2.3 million people worldwide suffer from multiple sclerosis (MS), a chronic disease in which the immune system incorrectly attacks healthy tissue in a person’s central nervous system. While MS is not a fatal disease, it affects a person’s vision and mobility, and can even cause paralysis in severe cases. There is no cure for MS, however, Celltex Therapeutics is using its proprietary stem cell culturing and banking technology to … read more


Local Alzheimer’s Association tours Celltex lab, learns more about stem cell banking and therapy

On Tuesday, Feb. 10, Celltex met with the Alzheimer’s Association Houston & Southeast Texas Chapter to provide a tour for their staff members through the stem cell processing and culturing lab and share the potential of stem cell use in regenerative therapies. This private tour is part of Celltex’s educational outreach initiatives aimed at engaging local organizations whose focus is on helping those with degenerative and autoimmune diseases and sharing information and resources about stem cell therapy that may benefit … read more


Mayo Clinic

Diagnosed in 2006 with renal artery stenosis, Ralph Johnsen was desperate for options. Johnsen turned to physicians at the Mayo Clinic, who were conducting a clinical trial in which an individual’s own stem cells were being used to repair a person’s  arteries and damaged tissues. Due to the overwhelming success of the trial and the large amount of “proof of concept data,” the National Institutes of Health agreed to provide funding for a five-year study, which began in 2014. Click … read more


Bring the Benefits of Stem Cell Banking to the People You Love

Celltex is now offering you the opportunity to extend the benefits of stem cell banking to your family members through its family banking discount. Once you’ve signed up, any additional family members can receive the family banking package, valued at $6,500 for 20% off ($5,200). This special offer provides family members with the security that their own mesenchymal stem cells will be safely banked for future therapeutic use. The family banking package has no expiration date and includes qualifying lab … read more


Adult Stem Cell Banking Improves Quality of Life

Local Recipients Show Marked Improvement After Stem Cell Treatments HOUSTON (February  18, 2015) — For most people, the new year is a time for reflection, planning and goal-setting, a time when everyone strives to figure out what will make them happier and healthier, but  people  rarely hear how those resolutions turn out. For three Houstonians suffering from three separate debilitating diseases, 2015 is starting with a marked improvement in health and quality of life thanks to help from Celltex Therapeutics … read more


UM study explores how stem cells can help burn victims

University of Miami doctors are conducting stem cell clinical trials in order to change the way burn victims are treated, including military personnel inured in the line of duty. The trial, funded by the Department of Defense, could revolutionize burn care for those in need of reconstructive skin graft surgery, especially soldiers.  Burn victims from the wars in Iraq and Afghanistan account for 5 to 20 percent of combat injuries. Participants in the trial will come from The University of … read more


Rotary Club of Oklahoma City invites Celltex to address members

As part of Celltex Therapeutic Corporation’s continued efforts in educating the public about the potential of stem cell therapy, Celltex Chief Medical Officer Dr. Stanley C. Jones and Vice President of Business Development Madison Mauze addressed members of the Memorial-Spring Branch Rotary Club on January 23 at the Racquet Club. Members of the group received an overview of Celltex Therapeutics Corporation and the company’s proprietary technology that makes it possible to bank hundreds of millions of one’s own adult stem … read more


Celltex Participates in Annual Anti-Aging Conference

Houston-based biotechnology company Celltex Therapeutics Corporation took part in the 22nd Annual World Congress on Anti- Aging Medicine in Las Vegas on December 10 – 14, 2014. The conference allowed practitioners from all specialties to gain the latest information on the world of anti-aging from over 70 world-renowned speakers, who delivered relevant, clinical and data-supported presentations over the course of the three-day conference. Representatives from Celltex took part in the 22nd Annual World Congress on Anti- Aging Medicine, educating attendees … read more


John Wade appointed to Celltex Board of Directors

Celltex Therapeutics Corporation has named John Wade, Senior and Managing Partner of Wade & Company, LLP, to its Board of Directors, effective November 11, 2014. Wade brings more than 43 years of experience in public accounting and currently serves as the primary accountant and finance counsel for Celltex Therapeutics Corporation. Throughout his career, Wade has provided solutions to a wide variety of tax problems and counseled private and public companies regarding general business and tax planning matters. His tax practice … read more


Steering stem cell trafficking into pancreas reverses type 1 diabetes

Researchers at Brigham and Women’s Hospital, a Harvard-affiliated hospital, have been studying mesenchymal stem cells (MSCs) and have reportedly uncovered a way to enhance and prolong the cells’ therapeutic efforts in type 1 diabetes.  While studying a preclinical trial of diabetic-prone mice, Harvard Medical School Professor Robert Sackstein and a team of researchers found that the intravenous administration of MSCs stifled pancreatic injuries by reducing the levels of sugar in the bloodstream of those mice without the need of insulin … read more